Aktie 4157 TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen TaiGen Biopharmaceuticals Holdings Limited

Aktien

4157

KYG866171005

4157

Schlusskurs Taipei Exchange
Andere Börsenplätze
 00:00:00 30.04.2024 		% 5 Tage % 1. Jan.
15,35 TWD -1,92 % Intraday Chart für TaiGen Biopharmaceuticals Holdings Limited -1,60 % +0,99 %
15.03. TaiGen Biopharmaceuticals Holdings Limited berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 TaiGen Biopharmaceuticals Holdings Limited meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2021
TaiGen Biopharmaceuticals Turns to Profit in 2021
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2021
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2020
TaiGen Biotechnology Company, Limited Partners with GPCR Therapeutics, Inc. to Develop Burixafor & Taigexyn(R)
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter Ended September 30, 2020
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2020
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2020
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2019
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2019
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2019
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 4157 Aktie
  4. Nachrichten TaiGen Biopharmaceuticals Holdings Limited
  5. Andere Sprachen